Disobutamide: a model agent for investigating intracellular drug storage

Area of Science:

• Pharmacology
• Toxicology
• Cell Biology

Background:

• Disobutamide is a bis tertiary amine and a potential cardiac antiarrhythmic agent.
• Cationic amphiphilic compounds can induce cellular vacuolation.
• Understanding drug-induced cellular changes is crucial for safety assessment.

Purpose of the Study:

• To investigate the nature and mechanism of cytoplasmic vacuole formation induced by disobutamide in vivo and in vitro.
• To determine if vacuole formation represents a toxic effect or a storage phenomenon.
• To explore the potential of disobutamide as a model compound for studying intracellular drug storage.

Main Methods:

• Administration of disobutamide to dogs and rats.
• Ultrastructural analysis of tissues using electron microscopy.
• In vitro studies using cultured cells to identify drug storage sites.
• Assessment of clinical signs and laboratory parameters for functional impairment.

Main Results:

• Disobutamide induced significant cytoplasmic vacuolation in dogs and rats.
• Ultrastructural examination revealed membrane-bound vesicles containing electron-lucent material and signs of phospholipidosis.
• No evidence of necrosis, inflammation, or functional impairment was observed.
• In cultured cells, vacuoles were identified as storage sites for disobutamide within acidic compartments like lysosomes and endosomes.

Conclusions:

• Disobutamide-induced vacuolation in vivo represents a storage phenomenon rather than overt toxicity.
• The drug is stored in acidic intracellular vesicles, consistent with its cationic amphiphilic nature.
• Disobutamide may serve as a valuable tool for studying intracellular drug storage mechanisms and the threshold between normal function and toxicity.